PRYADEINA et al.
246
(O–H, N–Hstretch), 1752, 1661 (C=O), 1614, 1525, 1496
X-ray diffraction study of compound VI. The single
1
(C=C, C=N, N–Hbend), 1204–1093 (C–F). H NMR
crystals were grown by slow evaporation of ethanol
solution. Crystals monoclinic, M 381.34, C17H17F2N3O5,
space group P21/c, a 13.0061(19), b 11.0239(17),
c 14.046(3) , α 90, β 113.989(15), γ 90 deg, V 1840.0(5)
3, Z 4, dcalc 1.377 g cm–3, μ(MoKα) 0.115 cm–1, (2θ)max
63.32°, λ 0.71073 , F(000) 792, –19 ≤ h ≤ 19, –15 ≤ k ≤
15, –20 ≤ l ≤ 20. The overall number of reflections (29584)
was measured on a diffractometer XCalibur 3 at 295(2)
K (ù/2θ-scanning, MoKα radiation, graphite mono-
chromator, CCD-detector), number of independent
reflections 5787 (Rint 0.0671), number of reflections with
Fo > 4σ(Fo) 1823. The structure was solved by the direct
method and refined by the least-squares method using
software SHELXL-97 [11] till R 0.0550, wR2 0.1026, GOF
1.000. The complete set of crystallographic data is
deposited into the Cambridge Structural Database
(registered number 662765) and is available at the address
CCDC, 12 Union Road, Cambridge CB2 1EZ, UK; fax:
+44 1223 336033; e-mail: deposit@ccdc.cam.ac.uk).
spectrum, δ, ppm: 0.88 t (3H, OCH2CH3, 3JH–H 7.0 Hz),
1.27 t (3H, OCH2CH3, 3JH–H 7.1 Hz), 3.58 d.d [1H, H3,
4
3J(H3–H4) 11.7, J(H3–OH) 1.1 Hz], 3.88 m (2H,
OCH2CH3, AΒ system, ΔAB 0.01, 2JH(A)–H(B) 10.9, 3JH–H
3
7.1 Hz), 4.22 q (2H, OCH2CH3, JH-H 7.0 Hz), 5.49 d
3
[1H, H4, J(H4–H3) 11.7 Hz], 6.58 s (1H, H6), 6.68 C
(1H, H1), 7.43–7.53 m (5H, Ph), 8.00 d [1H, OH, 4J(OH–
H3) 1.1 Hz]. 19F NMR spectrum, δ, ppm: 81.4 s (CF3).
Found, %: C 52.92; H 4.58; F 13.33; N 9.93.
C19H20F3N3O5. Calculated, %: C 53.40; H 4.72; F 13.33;
N 9.83.
Ethyl 2-hydroxy-8-nitro-2-trifluoromethyl-4-
phenyl-1,2,3,4-tetrahydroimidazo[1,5-a]pyrimi-
dine-3-carboxylate (IVc) was obtained similarly from
2.72 g (0.01 mol) of ester Ib and 1.37 g (0.01 mol) of
aminoimidazole hydrochloride IIb. Yield 2.48 g (62%),
colorless powder, mp 178–180°C. IR spectrum, ν, cm–1:
3363, 2963 (N–Hstretch, O–H), 1743 (C=O), 1632, 1610,
1535 (C=C, C=N, N–Hbend), 1488 (NO2), 1212–1078 (C–
F). 1H NMR spectrum, δ, ppm: 0.86 t (3H, OCH2CH3,
Initial esters I were prepared by procedure [12].
3
3JH–H 7.2 Hz), 3.74 d [1H, H3, J(H3–H4) 11.8 Hz],
8-methyl, 3-ethyl 2-hydroxy-2-difluoromethyl-4-
phenyl-1,2,3,4-tetrahydroimidazo[1,5-a]pyrimidine-
3,8-dicarboxylate (IVa). Amixture of 2.40 g (0.01 mol)
of ester Ia, 1.92 g (0.01 mol) of 5-aminoimidazole
hydrochloride (IIa), and 1.00 g (0.012 mol) of NaHCO3
in 10 ml of dry DMF was stirred for 8–12 h at 70°C, then
cooled and poured into water with ice (~100 ml), the
separated precipitate was filtered off, washed with warm
water and Et2O. Yield 2.77 g (70%), colorless powder,
mp 187–188°C. IR spectrum, ν, cm–1: 3359, 3110 (O–H,
N–Hstretch), 1709, 1654 (C=O), 1605, 1524, 1498 (C=C,
C=N, N–Hbend), 1056–1182 (C–F). 1H NMR spectrum,
δ, ppm: 1.26 t (3H, OCH2CH3, 3JH–H 7.1 Hz), 1.99 s (3H,
3.88 m (2H, OCH2CH3, AΒ system, ΔAB 0.02, 2JH(A)–H(B)
10.9, 3JH–H 7.1 Hz), 5.55 d [1H, H4, 3J(H4–H3) 11.8 Hz],
6.74 s (1H, H6), 7.44–7.46 m (3H, Ph), 7.58–7.60 m (2H,
Ph), 7.63 br.s (1H, OH), 8.28 s (1H, H1). 19F, δ, ppm:
81.88 s (CF3). Found, %: C 47.92; H 3.72; F 13.87; N 14.17.
C16H15F3N4O5. Calculated, %: C 48.01; H 3.78; F 14.00;
N 14.24.
Ethyl 5-hydroxy-5-trifluoromethyl-2,7-diphenyl-
4,5,6,7-tetrahydropyrazolo-[1,5-a]pyrimidine-6-
carboxylate (Va). A mixture of 2.72 g (0.01 mol) of
3-oxoester Ib and 1.91 g (0.01 mol) of 5-amino-3-
phenylpyrazole (III) in 10 ml of anhydrous DMF was
stirred for 5–6 h at 70°C, then cooled and poured into
water with ice (~100 ml), the separated precipitate was
filtered off and recrystallized from EtOH. Yield 3.02 g
(70%), colorless powder, mp 204–206°C. IR spectrum,
ν, cm–1: 3399, 3304, 2928 (N–Hstretch, O–H), 1715 (C=O),
1593, 1580, 1525, 1513 (C=C, C=N, N–Hbend), 1200–1092
(C–F). 1H NMR spectrum, δ, ppm: 0.88 t (3H, OCH2CH3,
3
4
OCH3), 3.56 d.d [1H, H3, J(H3–H4) 12.0, J(H3–OH)
3
0.9 Hz], 4.20 q (2H, OCH2CH3, JH–H 7.1 Hz), 5.53 d
3
2
[1H, H4, J(H4–H3) 12.0 Hz], 6.33 t (1H, HCF2, JH–F
54.6 Hz), 6.49 s (1H, H6), 6.92 s (1H, H1), 7.25 d [1H,
OH, J(OH–H3) 0.9 Hz], 7.42–7.47 m (5H, Ph). 19F NMR
spectrum, δ, ppm: 31.12 m (2F, HCF2, AΒ system, ΔAB
0.35, JF(A)–F(B) 279.0, JF–H 54.6 Hz). Found, %: C 55.00;
H 4.85; F 9.38; N 10.69. C18H19F2N3O5. Calculated, %:
C 54.69; H 4.84; F 9.60; N 10.63.
3
3JH–H 7.1 Hz), 3.33 d [1H, H6, J(H6–H7) 11.6 Hz],
3.88 m (2H, OCH2CH3, AB system, ΔAΒ 0.03, JH(A)–H(Β)
10.7, 3JH–H 7.1 Hz), 5.46 d [1H, H7, 3J(H7–H6) 11.6 Hz],
5.88 s (1H, H3), 7.22–7.54 m (10H, 2Ph), 7.56 s (1H,
OH), 7.86 s (1H, H4). 19F NMR spectrum, δ, ppm: 82.12 s
(CF3). Found, %: C 60.96; H 4.53; F 13.18; N 9.69.
C22H20F3N3O3. Calculated, %: C 61.25; H 4.67; F 13.21;
N 9.74.
Diethyl 2-hydroxy-2-trifluoromethyl-4-phenyl-
1,2,3,4-tetrahydroimidazo[1,5-a]-pyrimidine-3,8-
dicarboxylate (IVb) was obtained similarly from 2.72 g
(0.01 mol) of ester Ib. Yield 2.78 g (65%), colorless
powder, mp 115–116°C. IR spectrum, ν, cm–1: 3353, 3119
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 45 No. 2 2009